Human APIs Powder
- Respiratory Drugs Raw Material
- Antiviral Antibacterial
- Antipyretic Analgesics
- Antihistamine Drugs
- Antineoplastic
- Urinary System Drugs
- Endocrine System
- Other
Pharmaceutical
- Pharmaceutical intermediates
- Heterocyclic Compound
- OLED material intermediate
- Diphenylamine intermediates
- Nutritional Supplements
- Pharmaceutical raw materials
Medicine Excipients
Veterinary raw materials
Phone: 86-29-89601602
E-mail: sales21@interlgroup.com
Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
Arbidol CAS 131707-25-0 Raw Powder
Product Overview:
Arbidol Powder is a broad-spectrum antiviral medication used to treat and prevent various respiratory viral infections, including influenza, coronavirus, and respiratory syncytial virus (RSV). It was developed by a Russian pharmaceutical company and is also known by its generic name umifenovir. Arbidol CAS 131707-25-0 works by inhibiting the fusion of the virus with the host cell membrane, thereby preventing viral replication and spread. It is available in tablet and capsule form and is typically taken orally. While some studies suggest that Arbidol may be effective in treating COVID-19, more research is needed to confirm its efficacy.
Arbidol CAS 131707-25-0 Raw Powder Attributes
CAS: 131707-25-0
MF: C22H25BrN2O3S
Specification: 99% min Arbidol Powder
Sample: Arbidol Powder
Brand: Henrikang
Appearance: White Powder
Storage: Cool Dry Place
Shelf Life: 2 Years
Test Method: HPLC
Arbidol CAS 131707-25-0 Raw Powder Details
Arbidol Powder Usage and Synthesis:
Arbidol Powder is a broad-spectrum antiviral medication used to treat and prevent various respiratory viral infections, including influenza, coronavirus, and respiratory syncytial virus (RSV). It was developed by a Russian pharmaceutical company and is also known by its generic name umifenovir. Arbidol CAS 131707-25-0 works by inhibiting the fusion of the virus with the host cell membrane, thereby preventing viral replication and spread. It is available in tablet and capsule form and is typically taken orally. While some studies suggest that Arbidol may be effective in treating COVID-19, more research is needed to confirm its efficacy.
Abidor, a dual-action anti-influenza drug developed by the Soviet Union's Research Center for Medicinal Chemistry, is capable of fighting both influenza A and B viruses, and may also have antiviral activity against some other respiratory viral infections. it was first marketed in Russia in 1993 for use against influenza and other acute respiratory viral infections. Recent studies have shown that Arbidol effectively inhibits the novel pneumonia coronavirus.
Pharmacokinetics of Arbidol Powder:
Arbidol is a non-nucleoside antiviral drug that can block the replication of influenza virus by activating 2,5-oligoadenylate synthase, specifically preventing the contact, adhesion and fusion of influenza virus capsids with host cell membranes, and directly inhibiting viral RNA synthesis by penetrating into the cell nucleus.
On the other hand, it has immunomodulatory, interference-inducing and antioxidant properties, induces interferon production in host cells and stimulates humoral response and phagocytosis of macrophages, causing cellular and humoral immunity, and its antiviral effect is closely related to improving immune function. Abidor is mainly used for treatment and prophylaxis in children >2 years old and adults, and is only approved for marketing in Russia and China.
Applications of Arbidol Powder :
Arbidol is a non-nucleoside broad-spectrum antiviral drug with the main indication of influenza caused by influenza A and B viruses, and may also have antiviral activity against some other respiratory viral infections; in 2019, Arbidol was included for the first time in the national health insurance catalog and in the list of clinically recommended drugs for antiviral influenza issued by the National Health Care Commission.
Abidor Hydrochloride has the following eight features compared with other antiviral drugs.
1、Kill influenza A and B viruses at the same time.
2、Block virus fusion and replication.
3. Induces interferon and significantly improves autoimmunity.
4、Significantly reduce the symptoms of influenza and shorten the duration of influenza disease.
5、Prevent the occurrence and development of late influenza syndrome.
6、It can effectively prevent influenza when taken during influenza epidemic.
7、In vitro test, it has efficacy on SARS virus and avian influenza virus.
8、It is convenient to take orally, with high safety and good compliance.
Abidor is a preventive and therapeutic influenza drug, which blocks the replication of virus by inhibiting the fusion of influenza virus lipid membrane with the host cell. Studies have shown that it can directly inhibit the replication of influenza A and B viruses in in vitro cell culture and reduce the mortality of influenza virus-infected mice in in vivo animal tests. The product also has interferon-inducing effect.
![Our advantage](/skin/default/images/why.jpg)
![Our Factory](/skin/default/images/gs.jpg)
![Shipping](/skin/default/images/Shipping.jpg)